Loading…
Exenatide reduces oxidative stress and cell death in testis in iron overload rat model
Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron ove...
Saved in:
Published in: | Experimental and therapeutic medicine 2018-12, Vol.16 (6), p.4349-4356 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923 |
---|---|
cites | cdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923 |
container_end_page | 4356 |
container_issue | 6 |
container_start_page | 4349 |
container_title | Experimental and therapeutic medicine |
container_volume | 16 |
creator | Yesil, Suleyman Sungu, Nuran Kilicarslan, Aydan Kuskonmaz, Serife Mehlika Kara, Halil Kucuk, Aysegul Polat, Fazli Kavutcu, Mustafa Arslan, Mustafa |
description | Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several
and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue. |
doi_str_mv | 10.3892/etm.2018.6795 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6256837</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A565735368</galeid><sourcerecordid>A565735368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</originalsourceid><addsrcrecordid>eNptks9vFSEQx4nR2ObZo1dD4sXLPvmxsHAxaZpaTZp4Ua-EhaGl2YUK-17a_142fa3WCAcmw2e-ky8MQm8p2XKl2UdY5i0jVG3loMULdEwHzTpKqHh5iIlW9Aid1HpD2hKSKiVeoyNORC-5Jsfo5_kdJLtED7iA3zmoON9F3zJ7wHUpUCu2yWMH04Q92OUax4QXqEusaxRLTjjvoUzZelzsgufsYXqDXgU7VTg5nBv04_P597Mv3eW3i69np5ed6xVbOsqHoLhikgqvNeOW9CEE5wTrnXWMKu8lh17zcQRPKLAxcDkG56UImrWCDfr0oHu7G2fwDtJS7GRuS5xtuTfZRvP8JsVrc5X3RjIhFR-awIeDQMm_ds2WmWNdzdoEeVcNo2KQQuueNvT9P-hN3pXU7DWq15L1DfxDXdkJTEwht75uFTWnQoqBC94ab9D2P1TbHubocoIQW_5ZQfdQ4EqutUB48kiJWWfBtFkw6yyYdRYa_-7vh3miH3-e_wa7Ua8D</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2149624659</pqid></control><display><type>article</type><title>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</title><source>Open Access: PubMed Central</source><creator>Yesil, Suleyman ; Sungu, Nuran ; Kilicarslan, Aydan ; Kuskonmaz, Serife Mehlika ; Kara, Halil ; Kucuk, Aysegul ; Polat, Fazli ; Kavutcu, Mustafa ; Arslan, Mustafa</creator><creatorcontrib>Yesil, Suleyman ; Sungu, Nuran ; Kilicarslan, Aydan ; Kuskonmaz, Serife Mehlika ; Kara, Halil ; Kucuk, Aysegul ; Polat, Fazli ; Kavutcu, Mustafa ; Arslan, Mustafa</creatorcontrib><description>Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several
and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2018.6795</identifier><identifier>PMID: 30546390</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Apoptosis ; Biochemistry ; Cell death ; Clinical trials ; Control ; Dextrans ; Dosage and administration ; Endothelium ; Enzymes ; Exenatide ; Ferritin ; Glucagon ; Health aspects ; Hypoglycemic agents ; Immunohistochemistry ; Insulin ; Iron ; Iron (Nutrient) ; Laboratory animals ; Laboratory rats ; Medical research ; Oxidative stress ; Peptides ; Polysaccharides ; Rodents ; Studies ; Superoxides ; Testis ; Type 2 diabetes</subject><ispartof>Experimental and therapeutic medicine, 2018-12, Vol.16 (6), p.4349-4356</ispartof><rights>COPYRIGHT 2018 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2018</rights><rights>Copyright: © Yesil et al. 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</citedby><cites>FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256837/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256837/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30546390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yesil, Suleyman</creatorcontrib><creatorcontrib>Sungu, Nuran</creatorcontrib><creatorcontrib>Kilicarslan, Aydan</creatorcontrib><creatorcontrib>Kuskonmaz, Serife Mehlika</creatorcontrib><creatorcontrib>Kara, Halil</creatorcontrib><creatorcontrib>Kucuk, Aysegul</creatorcontrib><creatorcontrib>Polat, Fazli</creatorcontrib><creatorcontrib>Kavutcu, Mustafa</creatorcontrib><creatorcontrib>Arslan, Mustafa</creatorcontrib><title>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several
and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue.</description><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Cell death</subject><subject>Clinical trials</subject><subject>Control</subject><subject>Dextrans</subject><subject>Dosage and administration</subject><subject>Endothelium</subject><subject>Enzymes</subject><subject>Exenatide</subject><subject>Ferritin</subject><subject>Glucagon</subject><subject>Health aspects</subject><subject>Hypoglycemic agents</subject><subject>Immunohistochemistry</subject><subject>Insulin</subject><subject>Iron</subject><subject>Iron (Nutrient)</subject><subject>Laboratory animals</subject><subject>Laboratory rats</subject><subject>Medical research</subject><subject>Oxidative stress</subject><subject>Peptides</subject><subject>Polysaccharides</subject><subject>Rodents</subject><subject>Studies</subject><subject>Superoxides</subject><subject>Testis</subject><subject>Type 2 diabetes</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptks9vFSEQx4nR2ObZo1dD4sXLPvmxsHAxaZpaTZp4Ua-EhaGl2YUK-17a_142fa3WCAcmw2e-ky8MQm8p2XKl2UdY5i0jVG3loMULdEwHzTpKqHh5iIlW9Aid1HpD2hKSKiVeoyNORC-5Jsfo5_kdJLtED7iA3zmoON9F3zJ7wHUpUCu2yWMH04Q92OUax4QXqEusaxRLTjjvoUzZelzsgufsYXqDXgU7VTg5nBv04_P597Mv3eW3i69np5ed6xVbOsqHoLhikgqvNeOW9CEE5wTrnXWMKu8lh17zcQRPKLAxcDkG56UImrWCDfr0oHu7G2fwDtJS7GRuS5xtuTfZRvP8JsVrc5X3RjIhFR-awIeDQMm_ds2WmWNdzdoEeVcNo2KQQuueNvT9P-hN3pXU7DWq15L1DfxDXdkJTEwht75uFTWnQoqBC94ab9D2P1TbHubocoIQW_5ZQfdQ4EqutUB48kiJWWfBtFkw6yyYdRYa_-7vh3miH3-e_wa7Ua8D</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Yesil, Suleyman</creator><creator>Sungu, Nuran</creator><creator>Kilicarslan, Aydan</creator><creator>Kuskonmaz, Serife Mehlika</creator><creator>Kara, Halil</creator><creator>Kucuk, Aysegul</creator><creator>Polat, Fazli</creator><creator>Kavutcu, Mustafa</creator><creator>Arslan, Mustafa</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181201</creationdate><title>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</title><author>Yesil, Suleyman ; Sungu, Nuran ; Kilicarslan, Aydan ; Kuskonmaz, Serife Mehlika ; Kara, Halil ; Kucuk, Aysegul ; Polat, Fazli ; Kavutcu, Mustafa ; Arslan, Mustafa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Cell death</topic><topic>Clinical trials</topic><topic>Control</topic><topic>Dextrans</topic><topic>Dosage and administration</topic><topic>Endothelium</topic><topic>Enzymes</topic><topic>Exenatide</topic><topic>Ferritin</topic><topic>Glucagon</topic><topic>Health aspects</topic><topic>Hypoglycemic agents</topic><topic>Immunohistochemistry</topic><topic>Insulin</topic><topic>Iron</topic><topic>Iron (Nutrient)</topic><topic>Laboratory animals</topic><topic>Laboratory rats</topic><topic>Medical research</topic><topic>Oxidative stress</topic><topic>Peptides</topic><topic>Polysaccharides</topic><topic>Rodents</topic><topic>Studies</topic><topic>Superoxides</topic><topic>Testis</topic><topic>Type 2 diabetes</topic><toplevel>online_resources</toplevel><creatorcontrib>Yesil, Suleyman</creatorcontrib><creatorcontrib>Sungu, Nuran</creatorcontrib><creatorcontrib>Kilicarslan, Aydan</creatorcontrib><creatorcontrib>Kuskonmaz, Serife Mehlika</creatorcontrib><creatorcontrib>Kara, Halil</creatorcontrib><creatorcontrib>Kucuk, Aysegul</creatorcontrib><creatorcontrib>Polat, Fazli</creatorcontrib><creatorcontrib>Kavutcu, Mustafa</creatorcontrib><creatorcontrib>Arslan, Mustafa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Source (ProQuest)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yesil, Suleyman</au><au>Sungu, Nuran</au><au>Kilicarslan, Aydan</au><au>Kuskonmaz, Serife Mehlika</au><au>Kara, Halil</au><au>Kucuk, Aysegul</au><au>Polat, Fazli</au><au>Kavutcu, Mustafa</au><au>Arslan, Mustafa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exenatide reduces oxidative stress and cell death in testis in iron overload rat model</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>16</volume><issue>6</issue><spage>4349</spage><epage>4356</epage><pages>4349-4356</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>Glucagon-like peptide-1 (GLP-1) has been demonstrated to affect the oxidative stress status in several
and clinical studies. The aim of the present study was to evaluate the effect of a GLP-1 analogue, exenatide, on oxidative stress parameters and apoptotic markers in testicular cells in an iron overload rat model. To obtain this model, the animals were randomly divided into three groups (n=6/group). Rats in the control group received intraperitoneal injections of saline. Intraperitoneal iron dextran (60 mg/kg/day) was given to Group FE for 5 days a week for 4 weeks. The third group (Group Fe +E) was given subcutaneous injections of 10 µg/kg exenatide in two divided doses for 4 weeks in addition to iron dextran. Testes of all rats were immediately removed for immunohistochemical staining and to measure the malondialdehyde level and superoxide dismutase enzyme activity. A significant reduction was observed in caspase-8 and -3 enzyme staining in testicular stromal and endothelial cells in exenatide injected iron overloaded rats when compared with controls. Oxidative stress markers malondialdehyde levels and superoxide dismutase enzyme activities were also significantly lower in exenatide-injected rats when compared with controls. These findings indicate that exenatide may be protective against the harmful effects of iron accumulation in testis. Further studies are required to evaluate how exenatide reduces oxidative stress and cell death in iron overloaded testis tissue.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>30546390</pmid><doi>10.3892/etm.2018.6795</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1792-0981 |
ispartof | Experimental and therapeutic medicine, 2018-12, Vol.16 (6), p.4349-4356 |
issn | 1792-0981 1792-1015 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6256837 |
source | Open Access: PubMed Central |
subjects | Apoptosis Biochemistry Cell death Clinical trials Control Dextrans Dosage and administration Endothelium Enzymes Exenatide Ferritin Glucagon Health aspects Hypoglycemic agents Immunohistochemistry Insulin Iron Iron (Nutrient) Laboratory animals Laboratory rats Medical research Oxidative stress Peptides Polysaccharides Rodents Studies Superoxides Testis Type 2 diabetes |
title | Exenatide reduces oxidative stress and cell death in testis in iron overload rat model |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A13%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exenatide%20reduces%20oxidative%20stress%20and%20cell%20death%20in%20testis%20in%20iron%20overload%20rat%20model&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Yesil,%20Suleyman&rft.date=2018-12-01&rft.volume=16&rft.issue=6&rft.spage=4349&rft.epage=4356&rft.pages=4349-4356&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2018.6795&rft_dat=%3Cgale_pubme%3EA565735368%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-137f8382615d9923a04fffcc524cac218dd63e493bbed01e2bf36bfcd65f92923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2149624659&rft_id=info:pmid/30546390&rft_galeid=A565735368&rfr_iscdi=true |